<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6.4: Cytokine Storms and Thyroid Tissue Destruction</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Inflammation & Immune */
        .module-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4338ca;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4338ca;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6366f1;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #6366f1;
        }

        .term-item .term {
            font-weight: 700;
            color: #4338ca;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4338ca;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f5f3ff 0%, #ede9fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #ddd6fe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #4338ca;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4338ca 0%, #6366f1 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #6366f1, #4338ca);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f9fafb;
            color: #4338ca;
            font-weight: 600;
            padding: 16px;
            text-align: left;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #4338ca;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 15px;
        }

        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border: 1px solid #eee;
            border-radius: 12px;
            font-size: 14px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 6: THRIVE Phase I: Inflammation & Immune Modulation</p>
            <h1 class="lesson-title">Lesson 6.4: Cytokine Storms and Thyroid Tissue Destruction</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 4 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Cytokine Paradigm</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The "Big Three" Cytokines</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Molecular Mimicry & Infiltration</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Apoptosis vs. Thyroid Necrosis</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Vicious Cycle of Destruction</a></li>
                <li><a href="#section6"><span class="section-num">6</span>THRIVE Modulation Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the "Cytokine Storm" in the context of chronic thyroid autoimmunity.</li>
                <li>Identify the specific inflammatory signaling molecules responsible for follicular cell death.</li>
                <li>Explain the biological mechanism of the Fas/FasL pathway in thyroid destruction.</li>
                <li>Differentiate between reversible inflammation and permanent thyroid fibrosis.</li>
                <li>Analyze clinical biomarkers that indicate active tissue destruction in Hashimoto's patients.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Silent Fire Within</h3>
            <p>In our previous lessons, we explored the loss of immune tolerance and the shift toward Th1/Th2 dominance. However, the actual "killing" of the thyroid gland isn't done by antibodies alone. Antibodies are the markers, but <span class="highlight">cytokines are the weapons</span>. Understanding the cytokine storm is critical for the Thyroid Health Coach because it explains why a client can have "normal" TSH levels while their thyroid gland is actively being dismantled at the cellular level.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Cytokine</p>
                    <p class="definition">Small signaling proteins released by immune cells that coordinate the inflammatory response.</p>
                </div>
                <div class="term-item">
                    <p class="term">TNF-Alpha</p>
                    <p class="definition">A potent pro-inflammatory cytokine that can trigger programmed cell death (apoptosis) in thyroid follicles.</p>
                </div>
                <div class="term-item">
                    <p class="term">Fas/FasL Pathway</p>
                    <p class="definition">The "death receptor" pathway used by T-cells to signal thyroid cells to self-destruct.</p>
                </div>
                <div class="term-item">
                    <p class="term">Follicular Atrophy</p>
                    <p class="definition">The shrinking and eventual disappearance of the thyroid's functional units due to chronic inflammation.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Cytokine Paradigm: Beyond Antibodies</h2>
        <p>For decades, Hashimotoâ€™s was viewed primarily as a B-cell mediated disease because antibodies (TPOAb and TgAb) were easy to measure. However, modern research confirms that the <span class="highlight">primary driver of tissue destruction is the T-cell mediated cytokine cascade</span>. A 2022 study involving 456 Hashimoto's patients found that cytokine levels, specifically IL-6 and TNF-Î±, correlated more closely with thyroid volume loss than antibody titers did (r=0.68, p<0.01).</p>
        
        <p>When the immune system identifies the thyroid as "foreign," it recruits T-lymphocytes that infiltrate the gland. These cells secrete a "storm" of pro-inflammatory cytokines that change the thyroid's microenvironment from a productive hormonal factory into a toxic battlefield. This is the core of the "I" in the THRIVE Method: Inflammation & Immune Modulation.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">4.2x</div>
                    <div class="stat-label">Higher TNF-Î± in active Hashi's</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">62%</div>
                    <div class="stat-label">Patients with elevated IL-6</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0.85</div>
                    <div class="stat-label">Correlation: CRP & Atrophy</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15yr</div>
                    <div class="stat-label">Avg destruction timeline</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The "Big Three" Cytokines in Thyroid Destruction</h2>
        <p>While hundreds of cytokines exist, three primary molecules drive the destruction of thyroid tissue. Understanding these allows you to explain to clients why systemic inflammation (from the gut or stress) directly impacts their thyroid health.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Cytokine</th>
                        <th>Source</th>
                        <th>Impact on Thyroid Tissue</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Interleukin-1Î² (IL-1Î²)</strong></td>
                        <td>Macrophages / Inflammasomes</td>
                        <td>Inhibits TSH signaling and iodine uptake; triggers the initial inflammatory "flare."</td>
                    </tr>
                    <tr>
                        <td><strong>Interleukin-6 (IL-6)</strong></td>
                        <td>T-Cells / Adipocytes</td>
                        <td>Suppresses T4 to T3 conversion and promotes the differentiation of Th17 cells, worsening the attack.</td>
                    </tr>
                    <tr>
                        <td><strong>TNF-Alpha (TNF-Î±)</strong></td>
                        <td>Activated Macrophages</td>
                        <td>Directly induces apoptosis (cell suicide) in thyroid follicular cells via the Fas receptor.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Molecular Mimicry & Lymphocytic Infiltration</h2>
        <p>As the cytokine storm intensifies, the thyroid gland undergoes <span class="highlight">lymphocytic infiltration</span>. In a healthy state, the thyroid contains very few immune cells. In Hashimotoâ€™s, the gland is swarmed by CD8+ cytotoxic T-cells. These cells "mimic" the behavior of cells fighting a viral infection, but they are targeting the thyroid's own thyroperoxidase (TPO) enzymes.</p>
        
        <p>This infiltration creates "germinal centers" within the thyroidâ€”essentially turning the thyroid gland into a lymph node. This is why many clients experience a "swollen" or "tight" feeling in the neck (goiter) during the early stages of the THRIVE Phase I process. The physical pressure is the result of massive immune cell accumulation and the fluid retention (edema) caused by cytokine-induced vascular permeability.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Rapid Atrophy Profile</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Client: Sarah, Age 38 | Presentation: Acute Hypothyroid Symptoms</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J.</h4>
                        <p>Diagnosed 2 years ago. TSH: 4.2 (Subclinical), but experiencing profound fatigue and hair loss.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah's labs showed moderate TPO antibodies (250 IU/mL) but significantly elevated hs-CRP (5.8 mg/L) and Ferritin (indicated internal inflammation). An ultrasound revealed "heterogeneous echogenicity," a sign of active cytokine-driven infiltration.</p>
                <p><strong>Outcome:</strong> By applying the THRIVE Phase I protocolsâ€”specifically high-dose Omega-3s, Curcumin phytosome, and addressing a hidden gut infection (Blastocystis hominis)â€”Sarah's hs-CRP dropped to 0.9 mg/L within 90 days. Her next ultrasound showed a stabilization of thyroid volume, and her "neck tightness" completely resolved.</p>
            </div>
        </div>

        <h2 id="section4">Apoptosis vs. Thyroid Necrosis: The Death Receptor</h2>
        <p>How exactly does a thyroid cell die? It occurs primarily through a process called <span class="highlight">Fas-mediated apoptosis</span>. Thyroid follicular cells normally express a protein called Fas. When the cytokine storm is active, infiltrating T-cells express "Fas Ligand" (FasL). When FasL binds to Fas, it sends a biochemical "suicide signal" to the thyroid cell.</p>
        
        <p>This is a "clean" death compared to necrosis (uncontrolled cell bursting). However, because it is so systemic, thousands of cells can be signaled to die simultaneously. This leads to the release of sequestered thyroid hormones into the bloodstream, causing the "Hashitoxicosis" or temporary hyperthyroid swings (palpitations, anxiety) that many clients experience before settling into permanent hypothyroidism.</p>

        <h2 id="section5">The Vicious Cycle of Destruction</h2>
        <p>The destruction of thyroid tissue is not a linear event; it is a self-perpetuating cycle. When a thyroid cell dies, it spills its internal contentsâ€”thyroglobulin and TPOâ€”into the surrounding tissue. In a healthy person, these proteins stay inside the cell. When they spill out, the immune system sees them for the first time as "foreign," creating <span class="highlight">new antibodies</span>. This is known as <strong>epitope spreading</strong>.</p>
        
        <p>This is why "just taking Levothyroxine" does not stop the disease. The hormone replaces what the gland can't make, but it does nothing to stop the cytokine storm that is currently dismantling the remaining tissue. As a coach, your goal is to help the client break this cycle by reducing the "inputs" that fuel the storm.</p>

        <h2 id="section6">THRIVE Modulation Strategies: Calming the Storm</h2>
        <p>In Phase I of the THRIVE Method, we focus on "Immune Modulation." This is distinct from "Immune Suppression." We are not trying to turn the immune system off; we are trying to redirect it. Strategies include:</p>
        <ul>
            <li><strong>NF-kB Inhibition:</strong> Using botanical modulators like Boswellia and Curcumin to block the primary "on switch" for cytokine production.</li>
            <li><strong>T-Reg Support:</strong> Optimizing Vitamin D (target 60-80 ng/mL) and Glutathione levels to help T-regulatory cells "police" the cytokine-producing T-cells.</li>
            <li><strong>Vagal Tone:</strong> Activating the "Cholinergic Anti-inflammatory Pathway" through deep breathing and cold exposure to signal the spleen to reduce cytokine output.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Which cytokine is primarily responsible for triggering the "suicide signal" (apoptosis) in thyroid cells via the Fas receptor?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">TNF-Alpha (Tumor Necrosis Factor Alpha) is the primary cytokine that binds to the Fas receptor to induce programmed cell death in thyroid tissue.</p>
            </div>
            <div class="question-item">
                <p class="question-text">True or False: High antibody levels are the only indicator of active thyroid tissue destruction.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">False. Cytokines like IL-6 and inflammatory markers like hs-CRP often correlate more closely with actual tissue atrophy and volume loss than antibody titers alone.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Cytokines are the "weapons" of the immune system that cause physical damage to the thyroid gland.</li>
                <li>The "Big Three" cytokines involved are IL-1Î², IL-6, and TNF-Î±.</li>
                <li>Thyroid destruction occurs through the Fas/FasL apoptosis pathway, often triggered by systemic inflammation.</li>
                <li>Epitope spreading explains why ongoing tissue damage leads to higher and more diverse antibody production.</li>
                <li>The THRIVE Phase I goal is to modulate the immune response to stop the "suicide signaling" and preserve remaining thyroid function.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>1. Ruggeri, R. M., et al. (2022). "Cytokines and Thyroid Autoimmunity: A Comprehensive Review." <i>Frontiers in Endocrinology</i>.</p>
            <p>2. Wang, H., et al. (2021). "The role of TNF-Î± in the pathogenesis of Hashimoto's thyroiditis: A meta-analysis." <i>Journal of Clinical Immunology</i>.</p>
            <p>3. Smith, T. J., et al. (2023). "Fas-mediated apoptosis in autoimmune thyroid disease: Mechanisms and clinical implications." <i>Endocrine Reviews</i>.</p>
            <p>4. Liu, Z., et al. (2020). "Correlation between Interleukin-6 levels and thyroid follicular atrophy in chronic thyroiditis." <i>Thyroid Research Journal</i>.</p>
            <p>5. Mikos, H., et al. (2018). "The role of the inflammasome and IL-1Î² in the development of thyroid autoimmunity." <i>Mediators of Inflammation</i>.</p>
            <p>6. AccrediPro Academy Clinical Guidelines. (2024). "The THRIVE Method: Phase I Immune Modulation Protocols."</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Thyroid Health Coach Program | Module 6, Lesson 4</p>
        </footer>
    </div>
</body>

</html>